Vemurafenib Oral Tablet [Zelboraf]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Two novel cancer drugs and their companion diagnostics to predict treatment response were given a go-ahead to market in quick… (More)
Is this relevant?